BEFAST: The 6-Step Lifesaving Tool Changing Stroke Response in India
BEFAST: A 6-Step Guide to Spotting a Stroke Fast

In a medical emergency like a stroke, every second counts. The speed at which a stroke is identified can dramatically alter a patient's future, determining whether they make a full recovery or face lifelong neurological challenges. For paramedics and even bystanders in India, a simple tool called BEFAST has become a critical weapon in the fight against stroke, enabling faster and more accurate identification than older methods.

Decoding the BEFAST Acronym: A Minute to Save a Life

The BEFAST protocol consists of six straightforward checks that anyone can perform in under a minute. Each letter represents a classic sign of a stroke, with the initial letters addressing symptoms that older tools often missed.

B is for Balance. Check if the person has suddenly lost their balance. Are they unsteady on their feet, wobbling when trying to walk, or struggling with coordination? These can indicate a stroke in the cerebellum or brainstem, an area sometimes overlooked.

E is for Eyes. Look for sudden vision problems. This includes seeing double, a patch of lost vision, or complete blindness in one or both eyes. General blurriness is less critical; it's the acute, severe loss that signals a brain emergency.

F is for Face Drooping. Ask the person to smile or show their teeth. Does one side of the face droop or remain immobile while the other side moves normally? This facial asymmetry is a classic red flag.

A is for Arm Weakness. Instruct the person to close their eyes and hold both arms straight out with palms up. Watch if one arm drifts downward or cannot be held steady. This points to weakness on one side of the body.

S is for Speech Difficulty. Listen for slurred or garbled speech. The person may be unable to understand simple instructions or repeat a basic phrase like "The sky is blue."

T is for Time to Call Emergency Services. This is the most critical step. Note the exact time symptoms began or when the person was last seen normal. Immediately call for an ambulance and relay this crucial timeline to the responders. About 1.9 million brain neurons can die per minute without treatment.

The Evolution of Stroke Care: From Support to Swift Intervention

Stroke care has undergone a revolutionary transformation. In the early days of emergency medical services (EMS), stroke calls were often a low priority, with care limited to supportive measures like oxygen, as there were no treatments to reverse the damage.

The landscape changed in 1996 with the approval of alteplase, a clot-busting drug for acute ischemic strokes. This breakthrough made speed the central pillar of stroke response. Paramedics needed rapid assessment tools to identify strokes and rush patients to hospitals equipped to administer the drug within a narrow time window.

While the NIH Stroke Scale was effective in hospitals, it was too lengthy for ambulances. This led to the creation of simpler tools. The Cincinnati Prehospital Stroke Scale focused on face, arm, and speech. This was later adapted into the public-friendly FAST (Face, Arm, Speech, Time) campaign. However, these tools sometimes missed strokes that primarily affected balance or vision, leading to the more comprehensive BEFAST protocol.

New Treatments and Triage: Matching Patients with Advanced Care

Around 2015, another game-changer emerged: mechanical thrombectomy. This procedure involves physically removing a large clot from a brain artery using a device and can be effective up to 24 hours in select cases. However, not every hospital has this capability.

This disparity necessitated better field triage. After a positive BEFAST check, paramedics now often use severity scales like RACE or LAMS to score neurological deficits. A high score suggests a large vessel occlusion, requiring direct transport to a comprehensive stroke center with a thrombectomy suite, bypassing primary stroke centers that only administer clot-busting drugs.

Furthermore, the drug tenecteplase is simplifying treatment. Unlike alteplase, which requires a one-hour infusion, tenecteplase is given as a single, quick injection. It is more targeted to the clot and has a lower risk of bleeding, making it increasingly favored in pre-hospital and hospital protocols.

For the roughly 13% of strokes that are hemorrhagic (caused by bleeding), symptoms may include a thunderclap headache or extremely high blood pressure. These patients require immediate transport to a center with neurosurgical expertise.

The real-world impact is clear: a patient identified via BEFAST, triaged with a severity scale, and routed to the correct hospital experiences drastically reduced "door-to-needle" times. This coordinated effort, powered by public awareness and relentless EMS training, saves precious brain cells and function. In stroke care, where time is brain, half-measures are not an option, and knowledge of tools like BEFAST truly saves lives.